EPIC Program Annual Data Tables 2006-2007: Table VIII
| Rank by Number of Claims | Drug and Strength | Drug Type** | Number of Claims | EPIC Payments | Rank by Payment |
|---|---|---|---|---|---|
| Top 20 Totals | 2,516,022 | $167,269,707 | |||
| Percent of Top 20 Drugs to Total Paid Claims | 22.38% | 24.94% | |||
| 1 | PLAVIX (75 MG) | SS | 290,161 | $37,575,242 | 1 |
| 2 | TOPROL XL (50 MG) | BNMS | 204,216 | $5,888,524 | 20 |
| 3 | NORVASC (5 MG) | BNMS | 165,142 | $9,377,232 | 8 |
| 4 | FUROSEMIDE (40 MG) | Gen | 157,384 | $515,224 | 243 |
| 5 | LIPITOR (10 MG) | SS | 147,932 | $12,864,785 | 6 |
| 6 | TOPROL XL (100 MG) | BNMS | 131,133 | $5,943,605 | 19 |
| 7 | FOSAMAX (70 MG) | SS | 129,090 | $10,160,619 | 7 |
| 8 | NORVASC (10 MG) | BNMS | 127,459 | $9,189,307 | 9 |
| 9 | HYDROCHLOROTHIAZIDE (25 MG) | Gen | 116,690 | $294,915 | 398 |
| 10 | METOPROLOL TARTRATE (50 MG) | Gen | 107,960 | $350,461 | 346 |
| 11 | FUROSEMIDE (20 MG) | Gen | 107,295 | $315,829 | 369 |
| 12 | LIPITOR (20 MG) | SS | 107,017 | $13,520,582 | 5 |
| 13 | NEXIUM (40 MG) | SS | 106,826 | $18,736,004 | 2 |
| 14 | PROTONIX (40 MG) | SS | 103,978 | $13,848,921 | 4 |
| 15 | ATENOLOL (50 MG) | Gen | 91,731 | $414,201 | 296 |
| 16 | METFORMIN HCL (500 MG) | Gen | 91,524 | $1,110,541 | 128 |
| 17 | AMBIEN (10 MG) | BNMS | 86,389 | $6,427,421 | 16 |
| 18 | OMEPRAZOLE (20 MG) | Gen | 83,110 | $6,853,502 | 14 |
| 19 | ACTONEL (35 MG) | SS | 80,734 | $6,198,497 | 18 |
| 20 | ZETIA (10 MG) | SS | 80,251 | $7,684,295 | 12 |
* Table VIII lists the top 20 drugs ranked by number of adjudicated claims for the program year (October 1, 2006-September 30, 2007) as well as the percentage of the totals they represent for the year.
** Drug Type values are BNMS='Brand Name Multi-Source', Gen='Generic and SS='Sole Source'.
